The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Antiviral drugs for cytomegalovirus diseases
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl)guanine
Elion, G. B., Furman, P. A., Fyfe, J. A., Miranda, P. D., Beauchamp, L., & Schaeffer, H. J. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5716 · Cited by 1,591
Kimberlin, D. W., Lin, C.-Y., Sánchez, P. J., Demmler, G. J., Dankner, W., Shelton, M., Jacobs, R. F., Vaudry, W., Pass, R. F., Kiell, J. M., et al. (2003) · The Journal of Pediatrics · doi:10.1016/s0022-3476(03)00192-6 · Cited by 987
Paya, C., Humar, A., Dominguez, E., Washburn, K., Blumberg, E., Alexander, B., Freeman, R., Heaton, N., & Pescovitz, M. D. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00382.x · Cited by 880
Valacyclovir for the Prevention of Cytomegalovirus Disease after Renal Transplantation
Lowance, D., Neumayer, H.-H., Legendre, C. M., Squifflet, J.-P., Kovarik, J., Brennan, P. J., Norman, D., Mendez, R., Keating, M. R., Coggon, G. L., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905133401903 · Cited by 712
Acyclic nucleoside phosphonates: a key class of antiviral drugs
Clercq, E. D., & Holý, A. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1877 · Cited by 688
Ganciclovir Prophylaxis To Prevent Cytomegalovirus Disease after Allogeneic Marrow Transplant
Goodrich, J. M., Bowden, R. A., Fisher, L., Keller, C., Schoch, G., & Meyers†, J. D. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-3-199302010-00003 · Cited by 650
Boeckh, M., Leisenring, W., Riddell, S. R., Bowden, R. A., Huang, M.-L., Myerson, D., Stevens-Ayers, T., Flowers, M. E. D., Cunningham, T., & Corey, L. (2003) · Blood · doi:10.1182/blood-2002-03-0993 · Cited by 598
Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments
Gandhi, M. K., & Khanna, R. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01202-2 · Cited by 563
Limaye, A. P., Corey, L., Koelle, D. M., Davis, C. L., & Boeckh, M. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02607-6 · Cited by 509
Li, C., Greenberg, P., Gilbert, M., Goodrich, J., & Riddell, Sr. (1994) · Blood · doi:10.1182/blood.v83.7.1971.1971 · Cited by 494
Oral Ganciclovir for Patients with Cytomegalovirus Retinitis Treated with a Ganciclovir Implant
Martin, D. F., Kuppermann, B. D., Wolitz, R. A., Palestine, A. G., Li, H., & Robinson, C. A. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904083401402 · Cited by 485
Sullivan, V., Talarico, C. L., Stanat, S. C., Davis, M., Coen, D. M., & Biron, K. K. (1992) · Nature · doi:10.1038/358162a0 · Cited by 471
Self-citationKalil, A. C., Levitsky, J., Lyden, E., Stoner, J., & Freifeld, A. G. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-12-200512200-00005 · Cited by 389
A Controlled Trial of Ganciclovir to Prevent Cytomegalovirus Disease after Heart Transplantation
Merigan, T. C., Renlund, D. G., Keay, S., Bristow, M. R., Starnes, V., O'Connell, J. B., Resta, S., Dunn, D., Gamberg, P., Ratkovec, R. M., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204303261803 · Cited by 376
HO, E. S., LIN, D. C., MENDEL, D. B., & CIHLAR, T. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v113383 · Cited by 356
Hodson, E. M., Jones, C. A., Webster, A. C., Strippoli, G. F., Barclay, P. G., Kable, K., Vimalachandra, D., & Craig, J. C. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66553-1 · Cited by 350
Antiviral prodrugs – the development of successful prodrug strategies for antiviral chemotherapy
De Clercq, E., & Field, H. J. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706446 · Cited by 336
Whitley, R. J., Cloud, G., Gruber, W., Storch, G. A., Demmler, G. J., Jacobs, R. F., Dankner, W., Spector, S. A., Starr, S., Pass, R. F., et al. (1997) · The Journal of Infectious Diseases · doi:10.1086/516445 · Cited by 315
Treatment of Cytomegalovirus Retinitis with a Sustained-Release Ganciclovir Implant
Musch, D. C., Martin, D. F., Gordon, J. F., Davis, M. D., & Kuppermann, B. D. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707103370203 · Cited by 286
Krosky, P. M., Baek, M.-C., & Coen, D. M. (2003) · Journal of Virology · doi:10.1128/jvi.77.2.905-914.2003 · Cited by 241
Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients
Ljungman, P. (2001) · Blood · doi:10.1182/blood.v97.2.388 · Cited by 220
Congenital cytomegalovirus infection: Outcome and diagnosis
Ross, S. A., & Boppana, S. B. (2005) · Seminars in Pediatric Infectious Diseases · doi:10.1053/j.spid.2004.09.011 · Cited by 211
Underwood, M., Harvey, R. J., Stanat, S. C., Hemphill, M. L., Miller, T., Drach, J. C., Townsend, L. B., & Biron, K. K. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.717-725.1998 · Cited by 196
Self-citationTownsend, L. B., Devivar, R. V., Turk, S. R., Nassiri, M. R., & Drach, J. C. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00020a025 · Cited by 186
Ciesla, S. L., Trahan, J., Wan, W. B., Beadle, J. R., Aldern, K. A., Painter, G. R., & Hostetler, K. Y. (2003) · Antiviral Research · doi:10.1016/s0166-3542(03)00110-4 · Cited by 176
Wolf, D. G., Courcelle, C. T., Prichard, M. N., & Mocarski, E. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1895 · Cited by 170
Mattes, F. M., Hainsworth, E. G., Geretti, A. M., Nebbia, G., Prentice, G., Potter, M. N., Burroughs, A. K., Sweny, P., Hassan‐Walker, A. F., Okwuadi, S., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/383040 · Cited by 95
Reefschlaeger, J. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.6.757 · Cited by 94
Resistance of Human Cytomegalovirus to the Benzimidazole l -Ribonucleoside Maribavir Maps to UL27
Komazin, G., Ptak, R. G., Emmer, B. T., Townsend, L. B., & Drach, J. C. (2003) · Journal of Virology · doi:10.1128/jvi.77.21.11499-11506.2003 · Cited by 91
Mutations in the Human Cytomegalovirus UL27 Gene That Confer Resistance to Maribavir
Chou, S., Marousek, G. I., Senters, A. E., Davis, M. G., & Biron, K. K. (2004) · Journal of Virology · doi:10.1128/jvi.78.13.7124-7130.2004 · Cited by 90
Self-citationGriffiths, P., & Walter, S. (2005) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000168385.39390.1b · Cited by 84
Design and development of oral drugs for the prophylaxis and treatment of smallpox infection
Painter, G. R., & Hostetler, K. Y. (2004) · Trends in biotechnology · doi:10.1016/j.tibtech.2004.06.008 · Cited by 80
Progress toward an elusive goal: current status of cytomegalovirus vaccines
Schleiss, M. R., & Heineman, T. C. (2005) · Expert Review of Vaccines · doi:10.1586/14760584.4.3.381 · Cited by 74
Balfour, H. H. (1979) · Archives of Internal Medicine · doi:10.1001/archinte.1979.03630400011006 · Cited by 56
Fiddian, P. A., Sabin, C. A., & Griffiths, P. D. (2002) · The Journal of Infectious Diseases · doi:10.1086/342965 · Cited by 48
Cited by
Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients
Ljungman, P., Hakki, M., & Boeckh, M. (2011) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2010.11.011 · Cited by 423
Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation
Chemaly, R. F., Ullmann, A. J., Stoelben, S., Richard, M. P., Bornhäuser, M., Groth, C., Einsele, H., Silverman, M., Mullane, K. M., Brown, J., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1309533 · Cited by 378
INTRAVITREAL INJECTION OF THERAPEUTIC AGENTS
PEYMAN, G. A., LAD, E. M., & MOSHFEGHI, D. M. (2009) · Retina · doi:10.1097/iae.0b013e3181a94f01 · Cited by 255
Cytomegalovirus Infection: A Driving Force in Human T Cell Immunosenescence
KOCH, S., LARBI, A., ÖZCELIK, D., SOLANA, R., GOUTTEFANGEAS, C., ATTIG, S., WIKBY, A., STRINDHALL, J., FRANCESCHI, C., & PAWELEC, G. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1396.043 · Cited by 242
Principles of pharmacology in the eye
Awwad, S., Mohamed Ahmed, A. H. A., Sharma, G., Heng, J. S., Khaw, P. T., Brocchini, S., & Lockwood, A. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14024 · Cited by 224
“Standard therapy may include ganciclovir (Pollard, 1996; Martin et al., 1999), foscarnet (Berthe et al., 1994; López-Cortés et al., 2001) and cidofovir (Ljungman et al., 2001; Biron, 2006).”
Metadata
- Authors
- Biron, K. K.
- Venue
- Antiviral Research
- Publisher
- Elsevier BV
- Published
- 2006-09
- Volume
- 71
- Issue
- 2-3
- Pages
- 154-163
- ISSN
- 0166-3542 (ISSN-L)
- OpenAlex
- W2068392260
- Cited by
- 468
- References
- 36
- FWCI
- 19.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.